Vir Biotechnology, Inc.
Immunology company developing antibody therapies for serious infectious diseases and cancer.
VIR | US
Overview
Corporate Details
- ISIN(s):
- US92764N1028
- LEI:
- Country:
- United States of America
- Address:
- 1800 OWENS STREET, 94158 SAN FRANCISCO
- Website:
- https://www.vir.bio/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vir Biotechnology is a commercial-stage immunology company that leverages the human immune system to treat and prevent serious infectious diseases and cancer. The company's pipeline is built on advanced technology platforms, including a next-generation antibody platform and the PRO-XTEN™ masking technology, which enable the rapid development of antibody-based medicines. Vir's primary therapeutic focus is on infectious diseases, with a leading program in chronic hepatitis delta, complemented by strategic programs in oncology. The company has a proven ability to advance product candidates through clinical development and commercialization, having developed medicines for global health challenges such as COVID-19 and Ebola.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vir Biotechnology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vir Biotechnology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vir Biotechnology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
